Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
Calamos Convertible Opportunities and Income Fund (CHI), a closed-end fund focused on convertible securities and consistent income distribution, is trading at $11.65 as of 2026-04-13, marking a 0.34% decline on the day. This analysis covers key near-term technical levels, prevailing market context for hybrid income assets, and potential scenarios for CHI’s price action in upcoming sessions. No recent earnings data is available for the fund as of this analysis date, so technical and sector trend
Can Calamos Conv (CHI) Stock Beat Estimates | Price at $11.65, Down 0.34% - Take Profit
CHI - Stock Analysis
3094 Comments
822 Likes
1
Rushia
Insight Reader
2 hours ago
Could’ve made use of this earlier.
👍 192
Reply
2
Priyana
Senior Contributor
5 hours ago
Access real-time US stock market data with expert analysis and strategic recommendations focused on building a balanced portfolio. We provide free stock screening, fundamental research, sector analysis, and investment education through articles and tutorials. Our platform delivers comprehensive market coverage with real-time alerts to support your investment decisions. Experience professional-grade tools and personalized guidance for long-term growth with our beginner-friendly interface and advanced features.
👍 211
Reply
3
Birger
Daily Reader
1 day ago
I like how the report combines market context with actionable outlooks.
👍 121
Reply
4
Sakani
Active Contributor
1 day ago
Technical patterns suggest continued momentum, but watch for overextension.
👍 157
Reply
5
Dainon
Legendary User
2 days ago
The market is consolidating, providing a healthy base for future moves.
👍 147
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.